Venrock Associates Iv L P - Net Worth and Insider Trading
Venrock Associates Iv L P Net Worth
The estimated net worth of Venrock Associates Iv L P is at least $23,381 dollars as of 2024-04-17. Venrock Associates Iv L P is the 10% Owner of Bellerophon Therapeutics Inc and owns about 429,014 shares of Bellerophon Therapeutics Inc (BLPH) stock worth over $23,381. Venrock Associates Iv L P is also the 10% Owner of Anacor Pharmaceuticals Inc and owns about 0 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $0. Details can be seen in Venrock Associates Iv L P's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Venrock Associates Iv L P has not made any transactions after 2019-10-28 and currently still holds the listed stock(s).
Transaction Summary of Venrock Associates Iv L P
Venrock Associates Iv L P Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Venrock Associates Iv L P owns 6 companies in total, including Bellerophon Therapeutics Inc () , Quantenna Communications Inc () , and Achaogen Inc () among others .
Click here to see the complete history of Venrock Associates Iv L P’s form 4 insider trades.
Insider Ownership Summary of Venrock Associates Iv L P
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Bellerophon Therapeutics Inc | 2019-10-28 | 10 percent owner | |
Quantenna Communications Inc | 2016-11-02 | 10 percent owner | |
Achaogen Inc | 2014-03-17 | 10 percent owner | |
Anacor Pharmaceuticals Inc | 2013-11-15 | 10 percent owner | |
Acceleron Pharma Inc | 2013-09-18 | 10 percent owner | |
Alimera Sciences Inc | 2010-04-21 | 10 percent owner |
Venrock Associates Iv L P Latest Holdings Summary
Venrock Associates Iv L P currently owns a total of 2 stocks. Among these stocks, Venrock Associates Iv L P owns 429,014 shares of Bellerophon Therapeutics Inc (BLPH) as of October 28, 2019, with a value of $23,381 and a weighting of 100%. Venrock Associates Iv L P also owns 0 shares of Anacor Pharmaceuticals Inc (ANAC) as of November 15, 2013, with a value of $0 and a weighting of 0%.
Latest Holdings of Venrock Associates Iv L P
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BLPH | Bellerophon Therapeutics Inc | 2019-10-28 | 429,014 | 0.05 | 23,381 |
ANAC | Anacor Pharmaceuticals Inc | 2013-11-15 | 0 | 9.82 | 0 |
Holding Weightings of Venrock Associates Iv L P
Venrock Associates Iv L P Form 4 Trading Tracker
According to the SEC Form 4 filings, Venrock Associates Iv L P has made a total of 1 transactions in Bellerophon Therapeutics Inc (BLPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Bellerophon Therapeutics Inc is the sale of 72,923 shares on October 28, 2019, which brought Venrock Associates Iv L P around $525,047.
According to the SEC Form 4 filings, Venrock Associates Iv L P has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the sale of 150,000 shares on November 15, 2013, which brought Venrock Associates Iv L P around $2 Million.
Insider Trading History of Venrock Associates Iv L P
- 1
Venrock Associates Iv L P Trading Performance
GuruFocus tracks the stock performance after each of Venrock Associates Iv L P's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Venrock Associates Iv L P is 12.15%. GuruFocus also compares Venrock Associates Iv L P's trading performance to market benchmark return within the same time period. The performance of stocks bought by Venrock Associates Iv L P within 3 months outperforms 9 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Venrock Associates Iv L P's insider trading performs compared to the benchmark.
Performance of Venrock Associates Iv L P
Average Relative Return
-33.27%
Outperforming Transactions
27%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | 20.27 | 12.15 | -18.87 | -33.27 | -11.96 | -28.27 |
Relative Return to S&P 500(%) | 20.48 | 14.96 | -20.33 | -40.99 | -22.69 | -44.59 |
Venrock Associates Iv L P Ownership Network
Ownership Network List of Venrock Associates Iv L P
Ownership Network Relation of Venrock Associates Iv L P
Venrock Associates Iv L P Owned Company Details
What does Bellerophon Therapeutics Inc do?
Who are the key executives at Bellerophon Therapeutics Inc?
Venrock Associates Iv L P is the 10 percent owner of Bellerophon Therapeutics Inc. Other key executives at Bellerophon Therapeutics Inc include 10 percent owner Puissance Life Science Opportunities Fund Vi , VP of Business Operations Parag Suresh Shah , and See Remarks Martin Dekker .
Bellerophon Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Venrock Associates Iv L P made no insider transaction in Bellerophon Therapeutics Inc (). Other recent insider transactions involving Bellerophon Therapeutics Inc () include a net sale of 694,421 shares made by Puissance Capital Fund (gp) Llc , a net sale of 1,076,841 shares made by Puissance Life Science Opportunities Fund Vi , and a net sale of 9,455 shares made by Bobae Kim .
In summary, during the past 3 months, insiders sold 0 shares of Bellerophon Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,780,717 shares of Bellerophon Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,780,717 shares.
Bellerophon Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Bellerophon Therapeutics Inc Insider Transactions
Venrock Associates Iv L P Mailing Address
Above is the net worth, insider trading, and ownership report for Venrock Associates Iv L P. You might contact Venrock Associates Iv L P via mailing address: 3340 Hillview Avenue, Palo Alto Ca 94304.